Agape ATP Corporation reports company developments tied to its health and wellness business, green energy subsidiary, capital structure, and Nasdaq listing status. Recent announcements have covered Nasdaq minimum bid price compliance, energy-sector collaboration agreements, petroleum and petrochemical trading initiatives, private placement financing, shareholder voting matters, and governance actions.
The company's news also reflects its operating mix, including wellness products and advisory services, renewable-energy solutions, and commercial activity conducted through ATPC Green Energy Sdn. Bhd.
ATPC has signed an Irrevocable Corporate Purchase Order (ICPO) with Swiss One Oil & Gas AG for 200,000 metric tons of EN590 10PPM diesel and 2,000,000 barrels of Jet Fuel A1 in an initial trial phase. The strategic partnership aims to enhance oil and gas sales operations by combining ATPC's expertise in sustainable business strategies with Swiss One's experience in the oil and gas sector.
The collaboration focuses on optimizing supply chain efficiency through resource sharing, streamlined logistics, and integration of advanced technologies for inventory management and shipment tracking. Both companies will work together to expand market presence, improve operational efficiency, and implement environmentally responsible practices.
The partnership represents a significant step in ATPC's diversification strategy in the global energy sector, with both companies expected to benefit from increased market presence, cost efficiencies, and new trading opportunities.
ATPC has signed three Memorandums of Understanding (MOUs) with prominent Indonesian healthcare institutions to advance medical research and treatment strategies for respiratory diseases. The partnerships with Dr. Sardjito General Hospital, Dr. H. A. Rotinsulu Lung Hospital, and Dr. M. Goenawan Partowidigdo Respiratory Hospital focus on enhancing research capabilities, conducting clinical studies on ATPC's health products, and ensuring compliance with Indonesian health standards. The collaboration aims to address tuberculosis (TB) and chronic obstructive pulmonary disease (COPD), major health concerns in Indonesia, through advanced medical research, healthcare professional training, and innovative treatment approaches.
NASDAQ-listed Agape ATP (ATPC) unveils its six core business pillars aimed at addressing global challenges in sustainability, health, and quality of life. The pillars include:
1. ATPC Green Energy (AGE): Focuses on sustainable energy solutions and energy-saving projects in Malaysia and ASEAN countries.
2. Agape Superior Living (ASL): Develops anti-aging supplements like ATP2 for the wellness industry.
3. Cedar ATPC: Offers Myofascial Release Therapy and Pain Relief Therapy for improved physical well-being.
4. Senior Living: Creates supportive environments for elderly care.
5. Medical Devices: Collaborates with FORMEDIC Technologies to develop the LEGA device for respiratory care.
6. DSY Wellness: Provides nutraceuticals and nutritional medicine products.
ATPC aims to synergize these pillars to drive business growth while contributing to global wellness and sustainability.
NASDAQ-listed AGAPE ATP (ATPC) has announced a strategic collaboration with FORMEDIC Technologies to launch LEGA, an electronic chest percussion device for respiratory care. This partnership aims to address the growing demand for advanced respiratory solutions in a market estimated to reach USD 25.95 billion in 2024 and USD 49.84 billion by 2031.
LEGA, FORMEDIC's flagship product, assists patients with chronic obstructive pulmonary diseases (COPD), pneumonia, bronchiectasis, and other lung-related conditions. The device has already gained traction with nearly 2,000 units used in major hospitals and rehabilitation centres globally.
This collaboration allows ATPC to diversify its wellness portfolio and leverage FORMEDIC's expertise in healthcare technology. The partnership will focus on continuous R&D efforts and joint marketing strategies to position LEGA as a leading respiratory care solution globally.
Agape ATP (ATPC) has launched ATP2, an enhanced wellness supplement targeting key health challenges. The product features 76 essential minerals, 20 amino acids, and advanced enzymes to support overall wellness. ATP2 aims to address aging, metabolism, and chronic disease management through its unique blend of plant-based enzymes, minerals, amino acids, and hydrogen acetate technology.
ATPC targets selling 5,000 units by year-end. The product is designed to increase energy production by enhancing NADH+ levels in the body. ATP2's formula includes ingredients scientifically proven to improve metabolism, reduce inflammation, and reverse aging effects. It also manages blood pressure, blood sugar levels, and promotes cardiovascular health.
Manufactured in Malaysia, ATP2 incorporates advanced technologies from Australia, USA, Europe, and Japan. ATPC aims to align with UN Sustainable Development Goals, particularly in health and well-being, positioning ATP2 as a transformative solution in the wellness market.
Agape ATP (ATPC) has regained compliance with Nasdaq's minimum bid price rule. On September 17, 2024, ATPC received confirmation from Nasdaq's Listing Qualifications Department that its closing bid price had been $1.00 or greater for 10 consecutive trading days, from August 30 to September 16, 2024. This successful compliance with Nasdaq Listing Rule 5550(a)(2) resolves the previous listing concern, and the matter is now closed. The announcement marks a positive development for ATPC, ensuring its continued listing on the Nasdaq Stock Market.
ATPC Green Energy, a subsidiary of NASDAQ-listed AGAPE ATP (ATPC), has formed a strategic partnership with Xiamen Photons Solar Technology to develop solar photovoltaic (PV) mounting systems for Malaysia and ASEAN countries. This collaboration aims to boost renewable energy adoption and support carbon neutrality in the region. The partnership leverages Photons Solar's expertise in PV mounting systems and ATPC's local market knowledge to address grid stability and power supply challenges, particularly in Sabah. With Photons Solar's extensive experience, including over 5 GW in cumulative shipments and a 960,000 square meter manufacturing facility, the collaboration is set to accelerate the transformation of the ASEAN solar market and contribute to the region's zero-carbon energy future.
AGAPE ATP (NASDAQ:ATPC) has announced significant updates, including a 1-for-20 reverse stock split effective today. This move aims to increase the market price per share and meet NASDAQ's continued listing standards. The company is also reducing its authorized shares of common stock from 1,000,000,000 to 50,000,000.
ATPC is advancing several strategic initiatives, including:
- Launching new products to enhance financial outlook and market presence
- Expanding in the green energy sector through ATPC Green Energy Sdn. Bhd.
- Introducing new wellness services through Cedar ATPC Sdn. Bhd.
- Continuing growth in senior care services via Sweet Home Senior Living Care Centre Sdn Bhd
The company reports a strong balance sheet and is exploring new opportunities in domestic and regional markets, particularly in Wellness and Green Energy sectors.
AGAPE ATP (NASDAQ: ATPC) has announced a 1-for-20 reverse stock split effective August 30, 2024. This strategic move aims to increase the market price per share to comply with NASDAQ's continued listing standards. Key points include:
- Trading on a split-adjusted basis begins August 30, 2024
- Authorized shares reduced from 1,000,000,000 to 50,000,000
- Symbol remains 'ATPC' but with a new CUSIP number
- Company focuses on health and wellness products and energy-saving solutions
This corporate action is designed to maintain NASDAQ listing compliance, potentially impacting shareholder value and market perception.
NASDAQ-listed AGAPE ATP (ATPC) has announced strategic collaborations in the pain management and elderly care solutions markets. The company is partnering with Sweet Home Senior Living Care Centre to expand elderly care services, aiming to operate 10 facilities by 2026. Currently, there are 3 centers in Klang Valley, each housing an average of 14 seniors.
ATPC is also collaborating with Cedar Wellness to relaunch its wellness subsidiary as Cedar ATPC, focusing on non-pharmaceutical therapies and Traditional Chinese Medicine (TCM). These initiatives are part of ATPC's strategy to build a comprehensive wellness ecosystem and address the growing demand for holistic health solutions.